Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic GON Blockade in Veterans With PTH: Sub-study 1
NCT06069791Phase 1Completed
- Sponsor
- Yale University
- Start
- Jan 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine hydrochloride 0.75% injection in post-traumatic headache (PTH) (4 arms), sponsored by Yale University. Primary endpoints: Acute sensation felt during injection: quality, Acute sensation felt during injection: intensity and 4 more. Started Jan 2024; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT06069791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06069791.